These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34227028)

  • 1. DNMT1 Mediated CAHM Repression Promotes Glioma Invasion via SPAK/JNK Pathway.
    Xu Y; Li Z; Huai T; Huo X; Wang H; Bian E; Zhao B
    Cell Mol Neurobiol; 2022 Nov; 42(8):2643-2653. PubMed ID: 34227028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
    Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
    Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia.
    Pedersen SK; Mitchell SM; Graham LD; McEvoy A; Thomas ML; Baker RT; Ross JP; Xu ZZ; Ho T; LaPointe LC; Young GP; Molloy PL
    Epigenetics; 2014 Aug; 9(8):1071-82. PubMed ID: 24799664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity.
    Quan J; Ma C
    Environ Toxicol; 2024 Feb; 39(2):783-793. PubMed ID: 37782699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation.
    Hua CD; Bian EB; Chen EF; Yang ZH; Tang F; Wang HL; Zhao B
    Biomed Pharmacother; 2018 Oct; 106():678-685. PubMed ID: 29990858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.
    Gömöri E; Pál J; Kovács B; Dóczi T
    Diagn Pathol; 2012 Jan; 7():8. PubMed ID: 22264301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modification of miR-141 regulates SKA2 by an endogenous 'sponge' HOTAIR in glioma.
    Bian EB; Ma CC; He XJ; Wang C; Zong G; Wang HL; Zhao B
    Oncotarget; 2016 May; 7(21):30610-25. PubMed ID: 27121316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
    Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
    Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway.
    Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B
    J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells.
    Yao J; Zhou B; Zhang J; Geng P; Liu K; Zhu Y; Zhu W
    Tumour Biol; 2014 Aug; 35(8):7935-44. PubMed ID: 24833086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of Long Non-Coding RNA (LncRNA) Non-Coding RNA Activated by DNA Damage (NORAD) Inhibits Proliferation, Invasion, Migration, and Promotes Apoptosis of Glioma Cells via Downregulating the Expression of AKR1B1.
    Luo L; Chen C; He H; Cai M; Ling C
    Med Sci Monit; 2020 Jul; 26():e922659. PubMed ID: 32778640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SOCS2-AS1 promotes the progression of glioma via regulating ITGB1 expression.
    Wu D; Sun J; Wang H; Ma C
    Neurosci Lett; 2021 Nov; 765():136248. PubMed ID: 34536509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β-mediated repression of MST1 by DNMT1 promotes glioma malignancy.
    Guo Z; Li G; Bian E; Ma CC; Wan J; Zhao B
    Biomed Pharmacother; 2017 Oct; 94():774-780. PubMed ID: 28802229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPM2-AS inhibits the growth, migration, and invasion of gliomas through JNK, c-Jun, and RGS4.
    Bao MH; Lv QL; Szeto V; Wong R; Zhu SZ; Zhang YY; Feng ZP; Sun HS
    J Cell Physiol; 2020 May; 235(5):4594-4604. PubMed ID: 31637708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
    Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
    Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA NEAT1 promotes progression of glioma as a ceRNA by sponging miR-185-5p to stimulate DNMT1/mTOR signaling.
    Yu H; Xu A; Wu B; Wang M; Chen Z
    J Cell Physiol; 2021 Jan; 236(1):121-130. PubMed ID: 32803763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR-106b-5p/TUSC2 axis.
    Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
    Hum Cell; 2020 Apr; 33(2):416-426. PubMed ID: 32072565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
    Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
    Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ENST01108 promotes carcinogenesis of glioma by acting as a molecular sponge to modulate miR-489.
    Xu D; Liu R; Meng L; Zhang Y; Lu G; Ma P
    Biomed Pharmacother; 2018 Apr; 100():20-28. PubMed ID: 29421578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status.
    Li G; Wang Z; Zhang C; Liu X; Yang F; Sun L; Liang J; Hu H; Liu Y; You G; Bao Z; Zhang W; Wang Z; Jiang T
    Dis Markers; 2018; 2018():5975216. PubMed ID: 29887919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.